Clinical trial
Niacin, N-3 Fatty Acids and Insulin Resistance
NCT00286234 · University of South Dakota, Other · Completed
Key facts
| NCT number | NCT00286234 |
|---|---|
| Title | Niacin, N-3 Fatty Acids and Insulin Resistance |
| Official title | Niacin, N-3 Fatty Acids and Insulin Resistance |
| Lead sponsor | University of South Dakota, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Metabolic Syndrome, Hypertriglyceridemia |
| Intervention type | Drug |
| Interventions | omega-3 acid ethyl esters, extended release niacin, placebo, combined treatment |
| Enrollment | 68 |
| Start date | Oct 1, 2007 |
| Primary completion | Aug 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Feb 3, 2006 |
| Last update posted | Oct 26, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: